PLUS THERAPEUTICS, Inc. (PSTV) earnings
PSTV earnings moved a median of -2.78% by the close. Quarterly and annual PSTV reports and results, each read against the price at its own news timestamp. Back to the PSTV overview →
20 measured PSTV earnings events.
Where these PSTV earnings landedvs 20 measured PSTV earnings reactions
| Middle 50% of PSTV earnings reactions | -8.17% to +1.35% |
|---|---|
| Median reaction (to close) | -2.78% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 PSTV earnings events with a measured close landed between -8.17% and +1.35%; 30% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PLUS THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | +3.45% | +11.88% | |
| Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout | Press release | +3.45% | +11.88% | |
| Form 10-K PLUS THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | -5.46% | -9.09% | |
| Form 10-Q PLUS THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | -3.28% | +4.18% | |
| Form 10-Q PLUS THERAPEUTICS, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +4.65% | |
| Form 10-Q PLUS THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | -3.85% | -8.07% | |
| Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q | Press release | -0.03% | -2.97% | |
| Form NT 10-Q PLUS THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form NT | -7.57% | -8.70% | |
| Form 10-K/A PLUS THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | -1.58% | -8.44% | |
| Form 10-K PLUS THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | -2.80% | -4.67% | |
| Form 10-Q PLUS THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -8.59% | |
| Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Press release | +0.00% | -8.59% | |
| Form 10-Q PLUS THERAPEUTICS, INC. For: Jun 30 | SEC filing · Form 10-Q | +2.68% | -2.78% | |
| Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights | Press release | +2.68% | -2.78% | |
| Form 10-Q PLUS THERAPEUTICS, INC. For: Mar 31 | SEC filing · Form 10-Q | -0.64% | +1.35% | |
| Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights | Press release | -0.64% | +1.35% | |
| Form 10-K PLUS THERAPEUTICS, INC. For: Dec 31 | SEC filing · Form 10-K | +9.18% | -6.52% | |
| Form 10-Q PLUS THERAPEUTICS, INC. For: Sep 30 | SEC filing · Form 10-Q | -2.94% | -2.27% | |
| Plus Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights | Press release | -2.94% | -2.27% | |
| Plus Therapeutics to Announce Third Quarter 2023 Financial Results and Host Conference Call on October 31, 2023 | Press release | +0.00% | -2.68% |
Keep exploring
More PSTV: analyst actions → · SEC filings → · PSTV overview →